Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan for insulin resistance and fatty liver in adults with hypertension
ISRCTN03070108Phase 4Completed
- Sponsor
- Klinikum Chemnitz
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of telmisartan in hypertension (HTN), insulin resistance (IR), steatosis and 1 more (2 arms), sponsored by Klinikum Chemnitz. Started Feb 2010; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)insulin resistance (IR)steatosiscardiometabolic risk (CMR)
Beyond the preview
Go deeper on ISRCTN03070108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN03070108.